NCT05219760 is a NA clinical trial of LIVIA in Prolonged Grief Disorder, sponsored by Debrot Anik.

Who is sponsoring NCT05219760?

NCT05219760 is sponsored by Debrot Anik.

What drugs are being tested in NCT05219760?

Interventions in NCT05219760: LIVIA.

What condition does NCT05219760 study?

NCT05219760 studies Prolonged Grief Disorder.

Is NCT05219760 still recruiting?

NCT05219760 is currently completed. Last updated 8 September 2023.

Last reviewed 2023-09-08 · How we verify

NCT05219760

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LIVIA 2.0 : A RCT Of Two French Internet Intervention For Adults Struggling With Prolonged Grief Symptoms

Completed NA Last updated 8 September 2023

What this trial tests

NA trial testing LIVIA in Prolonged Grief Disorder in 64 participants. Completed in 10 August 2023.

Timeline

6 May 2022

Primary endpoint
31 January 2023

10 August 2023

Quick facts

Lead sponsor	Debrot Anik
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	prevention
Enrollment	64
Start date	6 May 2022
Primary completion	31 January 2023
Estimated completion	10 August 2023
Sites	1 location across Switzerland

Drugs / interventions tested

LIVIA

Conditions studied

Prolonged Grief Disorder — all drugs for Prolonged Grief Disorder →

Sponsor

Debrot Anik

Who can join

18 and older, any sex, with Prolonged Grief Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim to compare the efficacy of an IBI targeting complicated grief symptoms (LIVIA 2.0) compared to an already investigated IBI (LIVIA 1) using a guidance on demand design in a randomised controlled trial (RCT). More specifically, the investigators will test the following primary hypotheses: * Both interventions will significantly increase participants' well-being and decrease their distress, and those changes will be stable until follow-up. * LIVIA 2.0 will be more efficient than LIVIA 1 on all measure outcomes. * LIVIA 2.0 will have less dropouts than LIVIA 1.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Supporting People Who Have Lost a Close Person by Bereavement or Separation: Protocol of a Randomized Controlled Trial Comparing Two French-Language Internet-Based Interventions.
Debrot A, Kheyar M, Efinger L, Berthoud L, et al · · 2022 · cited 1× · PMID 35737454 · DOI 10.2196/39026
A French-Language Web-Based Intervention Targeting Prolonged Grief Symptoms in People Who Are Bereaved and Separated: Randomized Controlled Trial.
Debrot A, Efinger L, Kheyar M, Pomini V, et al · · 2024 · PMID 39412869 · DOI 10.2196/57294

Verify or expand the search:

Other recruiting trials for Prolonged Grief Disorder

Currently open trials in the same condition.

NCT06017765 — Coping After Loss Through Mindfulness in Adults With Prolonged Grief Disorder · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05219760 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Debrot Anik
Last refreshed: 8 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05219760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing